Garcinia mangostana peel extracts exhibit hepatoprotective activity against thioacetamide-induced liver cirrhosis in rats

Walaa Najm Abood, Sarwan W. Bradosty, Faiyaz Khudaboddin Shaikh, Nur'Ain Salehen, Reyhaneh Farghadani, Nabaz Fisal Shakir Agha, Morteta H. Al-Medhtiy, Treska Dhia Aldeen Kamil, Ali Salim Agha, Mahmood Ameen Abdulla

Research output: Contribution to journalArticleResearchpeer-review

33 Citations (Scopus)

Abstract

The study in vivo evaluated the influence of ethanolic extract of G. mangostana peel on the histology, immunohistochemistry, and biochemistry of thioacetamide (TAA) induced liver cirrhosis in Sprague Drawly (SD) rats. The rats were distinctly administered with two doses of G. mangostana (250 mg/kg and 500 mg/kg) with TAA showed a significant reduction in liver index and hepatocyte proliferation with much lesser cell damage. These groups were significantly down-regulated the PCNA, α-SMA, and TGF-β1. The liver homogenate exhibited increased antioxidant enzymes (SOD and CAT) activities accompanied with decline in malondialdehyde (MDA) level. The serum level of bilirubin, total protein, albumin and liver enzymes (ALP, ALT, and AST) were restored to normal and were comparable to that normal control and silymarin with TAA treated groups. Thus normal microanatomy of hepatocytes, suppression of PCNA, α-SMA, TGF-β, improved antioxidant enzymes, reduced MDA with restoration of liver biomarkers demonstrates hepatoprotective influence of G. mangostana.

Original languageEnglish
Article number104200
Number of pages11
JournalJournal of Functional Foods
Volume74
DOIs
Publication statusPublished - Nov 2020
Externally publishedYes

Keywords

  • Garcinia mangostana
  • Hepatoprotective effect
  • Liver cirrhosis
  • Thioacetamide
  • Traditional therapy

Cite this